DrugPatentWatch Database Preview
MOTRIN IB Drug Profile
» See Plans and Pricing
Which patents cover Motrin Ib, and when can generic versions of Motrin Ib launch?
Motrin Ib is a drug marketed by J And J Consumer Inc and is included in one NDA.
The generic ingredient in MOTRIN IB is ibuprofen. There are sixty-four drug master file entries for this compound. Two hundred and nine suppliers are listed for this compound. Additional details are available on the ibuprofen profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Motrin Ib
A generic version of MOTRIN IB was approved as ibuprofen by OHM on July 15th, 1986.
Summary for MOTRIN IB
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Suppliers / Packagers: | 3 |
| Bulk Api Vendors: | 175 |
| Clinical Trials: | 44 |
| Patent Applications: | 4,284 |
| Formulation / Manufacturing: | see details |
| What excipients (inactive ingredients) are in MOTRIN IB? | MOTRIN IB excipients list |
| DailyMed Link: | MOTRIN IB at DailyMed |
Recent Clinical Trials for MOTRIN IB
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| National Cancer Institute (NCI) | Phase 1 |
| City of Hope Medical Center | Phase 1 |
| Boston University | Phase 4 |
US Patents and Regulatory Information for MOTRIN IB
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| J And J Consumer Inc | MOTRIN IB | ibuprofen | TABLET;ORAL | 019012-003 | Dec 17, 1990 | OTC | Yes | No | Start Trial | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
